Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is cadmium a human carcinogen?

G Kazantzis1, R G Blanks, K R Sullivan

  • 1Imperial College of Science, Technology and Medicine, Royal School of Mines, London, United Kingdom.

IARC Scientific Publications
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An analysis of screen-detected invasive cancers by grade in the English breast cancer screening programme: are we failing to detect sufficient small grade 3 cancers?

European radiology·2020
Same author

Correction to: An analysis of 11.3 million screening tests examining the association between recall and cancer detection rates in the English NHS breast cancer screening programme.

European radiology·2019
Same author

An analysis of 11.3 million screening tests examining the association between needle biopsy rates and cancer detection rates in the English NHS Breast Cancer Screening Programme.

Clinical radiology·2019
Same author

An analysis of 11.3 million screening tests examining the association between recall and cancer detection rates in the English NHS breast cancer screening programme.

European radiology·2019
Same author

Role of performance metrics in breast screening imaging - where are we and where should we be?

Clinical radiology·2018
Same author

Disability and participation in breast and bowel cancer screening in England: a large prospective study.

British journal of cancer·2017

Cadmium exposure in workers shows no increased risk of prostate cancer. However, lung cancer risk is elevated, but confounding factors like arsenic exposure complicate attributing this solely to cadmium.

Area of Science:

  • Occupational Health
  • Environmental Toxicology
  • Epidemiology

Background:

  • Initial suspicions suggested a link between cadmium exposure and increased prostatic cancer mortality.
  • Previous studies indicated a potential association between cadmium exposure and elevated lung cancer mortality.
  • Confounding factors, including exposure to arsenic, nickel, beryllium, chromium, and heated mineral oils, complicated earlier interpretations.

Purpose of the Study:

  • To re-evaluate the mortality risks associated with occupational cadmium exposure.
  • To investigate the specific relationship between cadmium exposure intensity and lung cancer risk.
  • To assess the impact of confounding factors, particularly arsenic exposure, on observed mortality trends.

Main Methods:

  • Analysis of a long-term cohort mortality study involving workers from 17 plants in England.

Related Experiment Videos

  • Inclusion of data from various cadmium processing operations.
  • Assessment of exposure intensity to cadmium and other potential carcinogens, including arsenic.

    • Main Results:

    • No evidence of increased mortality from prostatic cancer was found in cadmium-exposed workers.
    • An increased mortality risk from lung cancer was observed, with a dose-response relationship suggested in some studies.
    • The updated 17-plant study confirmed an increased lung cancer risk related to cadmium exposure intensity but also indicated a potential association with arsenic exposure.

    Conclusions:

    • Current evidence does not support an increased risk of prostatic cancer mortality due to cadmium exposure.
    • The excess lung cancer mortality observed in cadmium-exposed workers cannot be definitively attributed to cadmium alone due to significant confounding factors.
    • Further investigation is ongoing to elucidate the specific roles of cadmium and co-exposures, such as arsenic, in the observed lung cancer risks.